Catherine T. Doherty Insider Trading $DGX QUEST DIAGNOSTICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Catherine T. Doherty.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Catherine T. Doherty. Catherine T. Doherty is SVP, Clin. Franchise Solutions in QUEST DIAGNOSTICS INC ($DGX) and SVP, Clinical Franchises in QUEST DIAGNOSTICS INC ($DGX) and SVP, Group Exec. Clin. Fran. in QUEST DIAGNOSTICS INC ($DGX) and SVP, Physician Services in QUEST DIAGNOSTICS INC ($DGX) and SVP, Physician Services Bus. in QUEST DIAGNOSTICS INC ($DGX).
Catherine T. Doherty in QUEST DIAGNOSTICS INC
Trading Symbol: DGXIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Catherine T. Doherty: SVP, Group Exec. Clin. Fran., SVP, Clin. Franchise Solutions, SVP, Clinical Franchises, SVP, Physician Services Bus.
Holdings: 68,729 shares
Current Value: $6,365,680
Latest Transaction: May 11 2021
$DGX Market Capitalization: $12.75B
$DGX Previous Close: $92.62
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Catherine T. Doherty in QUEST DIAGNOSTICS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 139.96 | 8,536 | 1,194,724 | 68,729 | 77.3 K to 68.7 K (-11.05 %) |
Mar 11 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 115.42 | 5,066 | 584,718 | 77,265 | 82.3 K to 77.3 K (-6.15 %) |
Mar 11 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 115.42 | 11,299 | 1,304,131 | 82,331 | 71 K to 82.3 K (+15.91 %) |
Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 121.19 | 524 | 63,504 | 71,032 | 71.6 K to 71 K (-0.73 %) |
Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 121.15 | 796 | 96,435 | 71,556 | 72.4 K to 71.6 K (-1.10 %) |
Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | A | 121.81 | 22,105 | 2,692,500 | 22,105 | |
Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 0.00 | 3,941 | 0 | 72,352 | 68.4 K to 72.4 K (+5.76 %) |
Sep 04 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | M | 66.51 | 58,392 | 3,883,652 | 0 | |
Sep 04 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 111.13 | 3,776 | 419,616 | 68,411 | 72.2 K to 68.4 K (-5.23 %) |
Sep 04 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 110.57 | 54,616 | 6,038,727 | 72,187 | 126.8 K to 72.2 K (-43.07 %) |
Sep 04 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Buy | M | 66.51 | 58,392 | 3,883,652 | 126,803 | 68.4 K to 126.8 K (+85.35 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 104.25 | 2,501 | 260,729 | 68,411 | 70.9 K to 68.4 K (-3.53 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 106.46 | 2,517 | 267,960 | 70,912 | 73.4 K to 70.9 K (-3.43 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 106.46 | 5,018 | 534,216 | 73,429 | 68.4 K to 73.4 K (+7.34 %) |
Feb 28 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 109.02 | 789 | 86,017 | 68,411 | 69.2 K to 68.4 K (-1.14 %) |
Feb 28 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 112.90 | 777 | 87,723 | 69,200 | 70 K to 69.2 K (-1.11 %) |
Feb 28 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 111.09 | 368 | 40,881 | 69,977 | 70.3 K to 70 K (-0.52 %) |
Feb 26 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 113.34 | 356 | 40,349 | 70,345 | 70.7 K to 70.3 K (-0.50 %) |
Feb 26 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 112.73 | 405 | 45,656 | 70,701 | 71.1 K to 70.7 K (-0.57 %) |
Feb 26 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 112.17 | 432 | 48,457 | 71,106 | 71.5 K to 71.1 K (-0.60 %) |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | A | 112.17 | 26,165 | 2,934,928 | 26,165 | |
Feb 20 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 0.00 | 4,012 | 0 | 71,538 | 67.5 K to 71.5 K (+5.94 %) |
Apr 08 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | M | 71.17 | 60,492 | 4,305,216 | 0 | |
Apr 08 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 90.59 | 5,890 | 533,587 | 67,526 | 73.4 K to 67.5 K (-8.02 %) |
Apr 08 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 90.59 | 60,492 | 5,480,152 | 73,416 | 133.9 K to 73.4 K (-45.17 %) |
Apr 08 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Buy | M | 71.17 | 60,492 | 4,305,216 | 133,908 | 73.4 K to 133.9 K (+82.40 %) |
Mar 05 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 86.86 | 3,777 | 328,070 | 73,416 | 77.2 K to 73.4 K (-4.89 %) |
Mar 05 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 86.86 | 7,669 | 666,129 | 77,193 | 69.5 K to 77.2 K (+11.03 %) |
Feb 28 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 87.84 | 1,066 | 93,637 | 69,524 | 70.6 K to 69.5 K (-1.51 %) |
Feb 27 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 88.24 | 363 | 32,031 | 70,590 | 71 K to 70.6 K (-0.51 %) |
Feb 25 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 88.39 | 336 | 29,699 | 70,953 | 71.3 K to 71 K (-0.47 %) |
Feb 20 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | A | 86.63 | 40,765 | 3,531,472 | 40,765 | |
Feb 20 2019 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 0.00 | 3,348 | 0 | 71,289 | 67.9 K to 71.3 K (+4.93 %) |
Mar 06 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 101.00 | 5,556 | 561,156 | 67,941 | 73.5 K to 67.9 K (-7.56 %) |
Mar 06 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 101.00 | 5,393 | 544,693 | 73,497 | 78.9 K to 73.5 K (-6.84 %) |
Mar 06 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 101.00 | 10,949 | 1,105,849 | 78,890 | 67.9 K to 78.9 K (+16.12 %) |
Mar 01 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 104.99 | 572 | 60,054 | 67,941 | 68.5 K to 67.9 K (-0.83 %) |
Mar 01 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 104.10 | 1,248 | 129,917 | 68,513 | 69.8 K to 68.5 K (-1.79 %) |
Mar 01 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 101.43 | 556 | 56,395 | 69,761 | 70.3 K to 69.8 K (-0.79 %) |
Feb 27 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 102.74 | 397 | 40,788 | 70,317 | 70.7 K to 70.3 K (-0.56 %) |
Feb 27 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 101.43 | 1,212 | 122,933 | 70,714 | 71.9 K to 70.7 K (-1.69 %) |
Feb 27 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 102.69 | 386 | 39,638 | 71,926 | 72.3 K to 71.9 K (-0.53 %) |
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | A | 103.57 | 33,103 | 3,428,478 | 33,103 | |
Feb 21 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 0.00 | 2,897 | 0 | 72,312 | 69.4 K to 72.3 K (+4.17 %) |
Jan 26 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | M | 52.17 | 21,294 | 1,110,802 | 0 | |
Jan 26 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 104.00 | 21,294 | 2,214,576 | 69,415 | 90.7 K to 69.4 K (-23.48 %) |
Jan 26 2018 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Buy | M | 52.17 | 21,294 | 1,110,802 | 90,709 | 69.4 K to 90.7 K (+30.68 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | M | 56.12 | 6,595 | 370,111 | 0 | |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | M | 57.61 | 44,000 | 2,534,620 | 0 | |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | M | 57.35 | 9,167 | 525,727 | 0 | |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 108.15 | 177 | 19,143 | 69,415 | 69.6 K to 69.4 K (-0.25 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 107.54 | 6,418 | 690,217 | 69,592 | 76 K to 69.6 K (-8.44 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 108.14 | 1,364 | 147,504 | 76,010 | 77.4 K to 76 K (-1.76 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 107.52 | 42,636 | 4,584,223 | 77,374 | 120 K to 77.4 K (-35.53 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 108.16 | 315 | 34,069 | 120,010 | 120.3 K to 120 K (-0.26 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 107.54 | 8,852 | 951,962 | 120,325 | 129.2 K to 120.3 K (-6.85 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Buy | M | 56.12 | 6,595 | 370,111 | 129,177 | 122.6 K to 129.2 K (+5.38 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Buy | M | 57.61 | 44,000 | 2,534,620 | 122,582 | 78.6 K to 122.6 K (+55.99 %) |
Jun 21 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Buy | M | 57.35 | 9,167 | 525,727 | 78,582 | 69.4 K to 78.6 K (+13.21 %) |
May 23 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Gift | G | 0.00 | 4,740 | 0 | 69,415 | 74.2 K to 69.4 K (-6.39 %) |
Mar 06 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 98.29 | 6,028 | 592,492 | 74,155 | 80.2 K to 74.2 K (-7.52 %) |
Mar 06 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 98.25 | 1,134 | 111,416 | 80,183 | 81.3 K to 80.2 K (-1.39 %) |
Mar 06 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 98.12 | 6,492 | 636,995 | 81,317 | 87.8 K to 81.3 K (-7.39 %) |
Mar 06 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 98.12 | 12,520 | 1,228,462 | 87,809 | 75.3 K to 87.8 K (+16.63 %) |
Mar 02 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 96.42 | 585 | 56,406 | 75,289 | 75.9 K to 75.3 K (-0.77 %) |
Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | A | 95.80 | 37,565 | 3,598,539 | 37,565 | |
Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 0.00 | 3,132 | 0 | 76,512 | 73.4 K to 76.5 K (+4.27 %) |
Feb 17 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Sell | S | 94.65 | 1,615 | 152,858 | 73,380 | 75 K to 73.4 K (-2.15 %) |
Feb 15 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Payment of Exercise | F | 93.85 | 1,740 | 163,299 | 74,995 | 76.7 K to 75 K (-2.27 %) |
Feb 01 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Option Exercise | M | 56.12 | 37,414 | 2,099,674 | 6,595 | |
Feb 01 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Option Exercise | M | 52.17 | 42,586 | 2,221,499 | 21,294 | |
Feb 01 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Sell | S | 90.40 | 37,414 | 3,382,076 | 76,735 | 114.1 K to 76.7 K (-32.78 %) |
Feb 01 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Buy | M | 56.12 | 37,414 | 2,099,674 | 114,149 | 76.7 K to 114.1 K (+48.76 %) |
Feb 01 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Sell | S | 91.61 | 11,486 | 1,052,255 | 76,735 | 88.2 K to 76.7 K (-13.02 %) |
Feb 01 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Sell | S | 90.42 | 31,100 | 2,812,031 | 88,221 | 119.3 K to 88.2 K (-26.06 %) |
Feb 01 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Buy | M | 52.17 | 42,586 | 2,221,499 | 119,321 | 76.7 K to 119.3 K (+55.50 %) |
Jun 01 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Option Exercise | M | 56.82 | 23,667 | 1,344,759 | 0 | |
Jun 01 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Option Exercise | M | 55.65 | 23,667 | 1,317,069 | 0 | |
Jun 01 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Sell | S | 77.26 | 23,667 | 1,828,607 | 76,735 | 100.4 K to 76.7 K (-23.57 %) |
Jun 01 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Sell | S | 77.27 | 23,667 | 1,828,702 | 100,402 | 124.1 K to 100.4 K (-19.08 %) |
Jun 01 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Buy | M | 56.82 | 23,667 | 1,344,759 | 124,069 | 100.4 K to 124.1 K (+23.57 %) |
Jun 01 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Buy | M | 55.65 | 23,667 | 1,317,069 | 100,402 | 76.7 K to 100.4 K (+30.84 %) |
Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Payment of Exercise | F | 66.51 | 1,305 | 86,796 | 82,618 | 83.9 K to 82.6 K (-1.55 %) |
Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Payment of Exercise | F | 67.01 | 922 | 61,783 | 83,923 | 84.8 K to 83.9 K (-1.09 %) |
Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Grant | A | 67.01 | 2,684 | 179,855 | 84,845 | 82.2 K to 84.8 K (+3.27 %) |
Feb 29 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Option Exercise | A | 66.51 | 58,392 | 3,883,652 | 58,392 | |
Feb 29 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Payment of Exercise | F | 66.44 | 422 | 28,038 | 82,161 | 82.6 K to 82.2 K (-0.51 %) |
Feb 29 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Grant | A | 0.00 | 4,511 | 0 | 82,583 | 78.1 K to 82.6 K (+5.78 %) |
Feb 18 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Payment of Exercise | F | 61.95 | 609 | 37,728 | 78,072 | 78.7 K to 78.1 K (-0.77 %) |
Apr 27 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Option Exercise | M | 51.20 | 23,667 | 1,211,750 | 0 | |
Apr 27 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Sell | S | 74.40 | 5,883 | 437,695 | 76,735 | 82.6 K to 76.7 K (-7.12 %) |
Apr 27 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Sell | S | 74.46 | 23,667 | 1,762,221 | 82,618 | 106.3 K to 82.6 K (-22.27 %) |
Apr 27 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Buy | M | 51.20 | 23,667 | 1,211,750 | 106,285 | 82.6 K to 106.3 K (+28.65 %) |
Mar 03 2015 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Payment of Exercise | F | 70.53 | 101 | 7,124 | 78,659 | 78.8 K to 78.7 K (-0.13 %) |
Mar 03 2015 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Grant | A | 0.00 | 270 | 0 | 78,760 | 78.5 K to 78.8 K (+0.34 %) |
Mar 03 2015 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Payment of Exercise | F | 70.53 | 1,323 | 93,311 | 78,490 | 79.8 K to 78.5 K (-1.66 %) |
Mar 03 2015 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Payment of Exercise | F | 71.25 | 662 | 47,168 | 79,813 | 80.5 K to 79.8 K (-0.82 %) |
Feb 25 2015 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Option Exercise | A | 71.17 | 60,492 | 4,305,216 | 60,492 | |
Feb 25 2015 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Grant | A | 0.00 | 4,919 | 0 | 80,475 | 75.6 K to 80.5 K (+6.51 %) |
Feb 18 2015 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Payment of Exercise | F | 71.41 | 638 | 45,560 | 75,556 | 76.2 K to 75.6 K (-0.84 %) |
Nov 05 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Option Exercise | M | 47.49 | 23,667 | 1,123,946 | 0 | |
Nov 05 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Sell | S | 62.19 | 23,667 | 1,471,910 | 76,183 | 99.9 K to 76.2 K (-23.70 %) |
Nov 05 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Buy | M | 47.49 | 23,667 | 1,123,946 | 99,850 | 76.2 K to 99.9 K (+31.07 %) |
Aug 11 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Option Exercise | M | 53.19 | 25,000 | 1,329,750 | 0 | |
Aug 11 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Sell | S | 60.12 | 25,000 | 1,502,900 | 76,171 | 101.2 K to 76.2 K (-24.71 %) |
Aug 11 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Buy | M | 53.19 | 25,000 | 1,329,750 | 101,157 | 76.2 K to 101.2 K (+32.83 %) |
May 21 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 57.72 | 551 | 31,804 | 76,157 | 76.7 K to 76.2 K (-0.72 %) |
Mar 03 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 52.92 | 661 | 34,977 | 76,685 | 77.3 K to 76.7 K (-0.85 %) |
Feb 27 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 53.34 | 661 | 35,258 | 77,346 | 78 K to 77.3 K (-0.85 %) |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Option Exercise | A | 52.17 | 63,880 | 3,332,300 | 63,880 | |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 52.56 | 1,441 | 75,732 | 78,007 | 79.4 K to 78 K (-1.81 %) |
Feb 18 2014 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Grant | A | 0.00 | 6,710 | 0 | 79,005 | 72.3 K to 79 K (+9.28 %) |
Sep 18 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Option Exercise | M | 52.25 | 27,621 | 1,443,059 | 0 | |
Sep 18 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Option Exercise | M | 52.25 | 15,713 | 820,926 | 27,621 | |
Sep 18 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Sell | S | 62.00 | 27,621 | 1,712,502 | 72,295 | 99.9 K to 72.3 K (-27.64 %) |
Sep 18 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Buy | M | 52.25 | 27,621 | 1,443,059 | 99,911 | 72.3 K to 99.9 K (+38.21 %) |
Sep 18 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Sell | S | 62.00 | 15,713 | 974,206 | 72,290 | 88 K to 72.3 K (-17.86 %) |
Sep 18 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Buy | M | 52.25 | 15,713 | 820,926 | 88,003 | 72.3 K to 88 K (+21.74 %) |
Aug 15 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Option Exercise | M | 40.43 | 33,000 | 1,334,108 | 0 | |
Aug 15 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Sell | S | 59.85 | 33,000 | 1,975,126 | 72,290 | 105.3 K to 72.3 K (-31.34 %) |
Aug 15 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Buy | M | 40.43 | 33,000 | 1,334,108 | 105,079 | 72.1 K to 105.1 K (+45.78 %) |
May 17 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 59.91 | 276 | 16,534 | 72,079 | 72.4 K to 72.1 K (-0.38 %) |
Mar 07 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 56.35 | 934 | 52,626 | 72,146 | 73.1 K to 72.1 K (-1.28 %) |
Mar 07 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Grant | A | 0.00 | 2,505 | 0 | 73,080 | 70.6 K to 73.1 K (+3.55 %) |
Mar 06 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 55.97 | 661 | 36,996 | 70,575 | 71.2 K to 70.6 K (-0.93 %) |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Option Exercise | A | 56.12 | 44,009 | 2,469,785 | 44,009 | |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Grant | A | 0.00 | 7,099 | 0 | 71,232 | 64.1 K to 71.2 K (+11.07 %) |
Feb 19 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 56.97 | 712 | 40,563 | 64,133 | 64.8 K to 64.1 K (-1.10 %) |
Feb 12 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 58.45 | 1,453 | 84,928 | 64,845 | 66.3 K to 64.8 K (-2.19 %) |
Aug 09 2012 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Option Exercise | M | 52.24 | 40,000 | 2,089,400 | 0 | |
Aug 09 2012 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Sell | S | 60.11 | 40,000 | 2,404,324 | 66,016 | 106 K to 66 K (-37.73 %) |
Aug 09 2012 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Buy | M | 52.24 | 40,000 | 2,089,400 | 105,914 | 65.9 K to 105.9 K (+60.69 %) |
May 18 2012 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Payment of Exercise | F | 57.18 | 343 | 19,613 | 65,914 | 66.3 K to 65.9 K (-0.52 %) |
Mar 02 2012 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Payment of Exercise | F | 58.24 | 3,248 | 189,164 | 66,156 | 69.4 K to 66.2 K (-4.68 %) |
Mar 02 2012 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Grant | A | 0.00 | 8,933 | 0 | 69,404 | 60.5 K to 69.4 K (+14.77 %) |
Feb 29 2012 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Option Exercise | A | 57.61 | 44,000 | 2,534,620 | 44,000 | |
Feb 29 2012 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Grant | A | 0.00 | 7,097 | 0 | 60,471 | 53.4 K to 60.5 K (+13.30 %) |
Feb 16 2012 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Payment of Exercise | F | 56.80 | 694 | 39,419 | 53,374 | 54.1 K to 53.4 K (-1.28 %) |
Feb 14 2012 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Payment of Exercise | F | 57.12 | 1,428 | 81,560 | 54,068 | 55.5 K to 54.1 K (-2.57 %) |
Feb 14 2012 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Payment of Exercise | F | 57.12 | 734 | 41,922 | 55,323 | 56.1 K to 55.3 K (-1.31 %) |
Page: 1